Leendert A. Trouw

13.1k total citations · 2 hit papers
218 papers, 9.8k citations indexed

About

Leendert A. Trouw is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Leendert A. Trouw has authored 218 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Rheumatology, 114 papers in Immunology and 91 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Leendert A. Trouw's work include Systemic Lupus Erythematosus Research (91 papers), Monoclonal and Polyclonal Antibodies Research (91 papers) and Rheumatoid Arthritis Research and Therapies (83 papers). Leendert A. Trouw is often cited by papers focused on Systemic Lupus Erythematosus Research (91 papers), Monoclonal and Polyclonal Antibodies Research (91 papers) and Rheumatoid Arthritis Research and Therapies (83 papers). Leendert A. Trouw collaborates with scholars based in Netherlands, Sweden and United States. Leendert A. Trouw's co-authors include René E. M. Toes, T. Huizinga, Anna M. Blom, Mohamed R. Daha, Cees van Kooten, Andreas Sjöberg, Marc A. Seelen, Jing Shi, Diane van der Woude and Annette H M van der Helm–van Mil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Leendert A. Trouw

209 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage

2011 414 citations Parawee Suwannalai, George M. C. Janssen et al. Proceedings of the National Academy of Sciences profile →
Production of complement components by cells of the immune system

2017 347 citations Rosalie Lubbers, Mieke F. van Essen et al. Clinical & Experimental Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leendert A. Trouw Netherlands	55	4.7k	4.6k	2.7k	1.5k	1.2k	218	9.8k
Falk Hiepe Germany	54	7.2k 1.5×	4.8k 1.0×	2.3k 0.8×	1.4k 0.9×	1.0k 0.9×	250	11.8k
Shozo Izui Switzerland	61	9.1k 1.9×	3.7k 0.8×	3.4k 1.3×	2.8k 1.8×	1.1k 0.9×	277	13.1k
Francesco Tedesco Italy	53	5.4k 1.1×	1.7k 0.4×	1.1k 0.4×	1.4k 0.9×	1.9k 1.5×	190	9.3k
Tsuneyo Mimori Japan	59	3.2k 0.7×	6.0k 1.3×	1.4k 0.5×	3.2k 2.1×	847 0.7×	396	12.9k
Pierre Youinou France	56	5.4k 1.1×	4.2k 0.9×	2.0k 0.7×	1.8k 1.2×	1.1k 0.9×	476	12.6k
Vivianne Malmström Sweden	53	6.6k 1.4×	4.1k 0.9×	2.2k 0.8×	1.8k 1.1×	617 0.5×	195	11.6k
Keith B. Elkon United States	70	10.1k 2.1×	5.0k 1.1×	2.2k 0.8×	4.7k 3.1×	897 0.7×	203	16.4k
Mary K. Crow United States	66	8.5k 1.8×	7.7k 1.7×	1.6k 0.6×	2.4k 1.6×	692 0.6×	184	14.4k
Timothy J. Vyse United Kingdom	44	5.7k 1.2×	3.7k 0.8×	1.1k 0.4×	1.7k 1.1×	352 0.3×	121	8.6k
Yoshinari Takasaki Japan	44	2.7k 0.6×	3.1k 0.7×	1.2k 0.4×	1.7k 1.1×	433 0.4×	295	7.0k

Countries citing papers authored by Leendert A. Trouw

Since Specialization

Citations

This map shows the geographic impact of Leendert A. Trouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leendert A. Trouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leendert A. Trouw more than expected).

Fields of papers citing papers by Leendert A. Trouw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leendert A. Trouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leendert A. Trouw. The network helps show where Leendert A. Trouw may publish in the future.

Co-authorship network of co-authors of Leendert A. Trouw

This figure shows the co-authorship network connecting the top 25 collaborators of Leendert A. Trouw. A scholar is included among the top collaborators of Leendert A. Trouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leendert A. Trouw. Leendert A. Trouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kissel, Theresa, Diane van der Woude, Karin A. van Schie, et al.. (2025). Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nature Communications. 16(1). 1582–1582. 2 indexed citations

Wang, Haiyu, et al.. (2025). Autoantibodies and therapeutic antibodies against complement factor H. Immunology Letters. 274. 107002–107002. 4 indexed citations

Ovcinnikovs, Vitalijs, Karin Dijkman, Gijs G. Zom, Frank J. Beurskens, & Leendert A. Trouw. (2024). Enhancing complement activation by therapeutic anti-tumor antibodies: Mechanisms, strategies, and engineering approaches. Seminars in Immunology. 77. 101922–101922. 10 indexed citations

Vries, Aiko P. J. de, Fréderike J. Bemelman, Ton J. Rabelink, et al.. (2024). Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy. Kidney International Reports. 9(6). 1919–1922. 2 indexed citations

Pongrácz, Tamás, Maaike Biewenga, Marco R. Bladergroen, et al.. (2024). Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases. Journal of Translational Medicine. 22(1). 456–456. 3 indexed citations

Bovenkamp, Fleur S. van de, Jos Pool, Cynthia S. M. Kramer, et al.. (2023). Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation. Proceedings of the National Academy of Sciences. 120(50). e2310666120–e2310666120. 9 indexed citations

Winkelhorst, Dian, Hans J. Baelde, Lotte E. van der Meeren, et al.. (2021). Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study. International Journal of Molecular Sciences. 22(13). 6763–6763. 10 indexed citations

Bovenkamp, Fleur S. van de, et al.. (2021). Circulating C1q levels in health and disease, more than just a biomarker. Molecular Immunology. 140. 206–216. 29 indexed citations

Dijkman, Karin, Rosalie Lubbers, Tom H. M. Ottenhoff, et al.. (2020). Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis. Scientific Reports. 10(1). 6290–6290. 15 indexed citations

10.

Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2019). In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Research & Therapy. 21(1). 28–28. 45 indexed citations

11.

Lubbers, Rosalie, Rosanne A. van Schaarenburg, Joanneke C. Kwekkeboom, et al.. (2019). Complement component C1q is produced by isolated articular chondrocytes. Osteoarthritis and Cartilage. 28(5). 675–684. 20 indexed citations

12.

Lubbers, Rosalie, Mieke F. van Essen, Cees van Kooten, & Leendert A. Trouw. (2017). Production of complement components by cells of the immune system. Clinical & Experimental Immunology. 188(2). 183–194. 347 indexed citations breakdown →

13.

Verheul, Marije K., Peter A. van Veelen, Arnoud de Ru, et al.. (2017). Pitfalls in the detection of citrullination and carbamylation. Autoimmunity Reviews. 17(2). 136–141. 38 indexed citations

14.

Hitchon, Carol, et al.. (2016). Are rheumatoid factor, anti-citrullinated protein antibodies, and anti-carbamylated protein antibodies linked by posttranslational modification of IgG? Comment on the article by Koppejan et al Reply. Data Archiving and Networked Services (DANS). 68(11). 2826–2827. 1 indexed citations

15.

Humphreys, Jennifer, Marije K. Verheul, Anne Barton, et al.. (2015). Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register. The Lancet. 385. S44–S44. 13 indexed citations

16.

Huizinga, T., Seán Connolly, Alyssa Johnsen, et al.. (2015). Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate. Data Archiving and Networked Services (DANS). 67. 1 indexed citations

17.

Veelen, Peter A. van, Michael Mähler, George M. C. Janssen, et al.. (2013). Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmunity Reviews. 13(3). 225–230. 95 indexed citations

18.

Suwannalai, Parawee, Lotte A van de Stadt, Helga Radner, et al.. (2011). Avidity maturation of ACPA in rheumatoid arthritis.. Data Archiving and Networked Services (DANS). 1 indexed citations

19.

Trouw, Leendert A., Marcin Okrój, Koba Kupreishvili, et al.. (2008). C4b-Binding Protein Is Present in Affected Areas of Myocardial Infarction during the Acute Inflammatory Phase and Covers a Larger Area than C3. PLoS ONE. 3(8). e2886–e2886. 15 indexed citations

20.

Trouw, Leendert A., Sara C. Nilsson, Isabel Gonçalves, Göran Landberg, & Anna M. Blom. (2005). C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. The Journal of Experimental Medicine. 201(12). 1937–1948. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact